"Additionally, Cynata is responding to enquiries and is in active discussions with international pharmaceutical
companies and other parties about the potential of its Cymerus MSCs to be a useful adjunct in the management of
patients with serious and ongoing issues associated with COVID-19 infection."
"Additionally, Cynata is responding to enquiries and is in...
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
32.5¢ |
Change
0.030(10.2%) |
Mkt cap ! $58.38M | |||
| Open | High | Low | Value | Volume |
| 29.5¢ | 33.0¢ | 29.0¢ | $129.5K | 419.8K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2650 | 31.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 32.5¢ | 9796 | 1 |
View Market Depth
| Last trade - 16.10pm 29/05/2024 (20 minute delay) ? |
|
|||||
|
Last
32.0¢ |
Change
0.030 ( 8.47 %) |
||||
| Open | High | Low | Volume | ||
| 29.5¢ | 33.0¢ | 29.0¢ | 92341 | ||
| Last updated 15.57pm 29/05/2024 ? | |||||
| CYP (ASX) Chart |